Does USTEKINUMAB-STBA Cause Condition aggravated? 12 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Condition aggravated have been filed in association with USTEKINUMAB-STBA. This represents 6.5% of all adverse event reports for USTEKINUMAB-STBA.
12
Reports of Condition aggravated with USTEKINUMAB-STBA
6.5%
of all USTEKINUMAB-STBA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Condition aggravated From USTEKINUMAB-STBA?
Of the 12 reports, 3 (25.0%) required hospitalization.
Is Condition aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB-STBA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB-STBA Cause?
Intentional product use issue (46)
Off label use (43)
Intentional dose omission (21)
Crohn's disease (20)
Death (15)
Haematochezia (13)
Diarrhoea (10)
Colitis ulcerative (8)
Psoriasis (8)
Abdominal pain (6)
What Other Drugs Cause Condition aggravated?
TOFACITINIB (16,925)
INFLIXIMAB (16,616)
DUPILUMAB (16,459)
ETANERCEPT (15,897)
METHOTREXATE (14,938)
ADALIMUMAB (13,527)
PREDNISONE (10,751)
INFLIXIMAB-DYYB (10,275)
HYDROXYCHLOROQUINE (8,848)
RITUXIMAB (8,627)
Which USTEKINUMAB-STBA Alternatives Have Lower Condition aggravated Risk?
USTEKINUMAB-STBA vs VADADUSTAT
USTEKINUMAB-STBA vs VALACYCLOVIR
USTEKINUMAB-STBA vs VALBENAZINE
USTEKINUMAB-STBA vs VALBENAZINE DITOSYLATE
USTEKINUMAB-STBA vs VALDECOXIB